UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C.  20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): July 27, 2004

 

EPIX Medical, Inc.

(Exact name of registrant as specified in its charter)

 

 

71 Rogers Street
Cambridge, Massachusetts 02142

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (617) 250-6000

 

 

Item 7.  Financial Statements and Exhibits.

 

(c) The following exhibits are furnished with this report:

 

Exhibit Number		Description
99.1		Press Release dated July 27, 2004.

 

Item 12.  Disclosure of Results of Operations and Financial Condition.

 

On July 27, 2004, the Registrant issued a press release to report its financial results for the second quarter ended June 30, 2004.  A copy of the press release is attached to this current report on Form 8-K as Exhibit 99.1.

 

The information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

	EPIX Medical, Inc.
	(Registrant)
Date: July 27, 2004	/s/ Peyton J. Marshall
		Peyton J. Marshall
		Senior Vice-President,
		Finance and Administration,
		Chief Financial Officer

 

3